AVTR
$7.51-0.10 (-1.31%)
Avantor, Inc.
Recent News
Longleaf Partners Global Fund Increased Its Stake in Avantor (AVTR)
Longleaf Partners, managed by Southeastern Asset Management, released its fourth-quarter 2025 investor letter for “Longleaf Partners Global Fund”. A copy of the letter can be downloaded here. The Fund returned 5.27% in the quarter, compared to the MSCI World’s 3.12 % and the MSCI World Value’s 3.34% return. The Fund returned 16.72% for the year, compared […]
New Strong Sell Stocks for March 17th
AVTR, COIN and CMG have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2026.
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock
Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology clients worldwide.
Avantor (AVTR): Buy, Sell, or Hold Post Q4 Earnings?
Avantor has gotten torched over the last six months - since September 2025, its stock price has dropped 38% to a new 52-week low of $7.88 per share. This may have investors wondering how to approach the situation.
Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.